Search

Your search keyword '"Yolande Lievens"' showing total 39 results

Search Constraints

Start Over You searched for: Author "Yolande Lievens" Remove constraint Author: "Yolande Lievens" Publication Year Range Last 3 years Remove constraint Publication Year Range: Last 3 years
39 results on '"Yolande Lievens"'

Search Results

1. Challenges in assessing national radiotherapy costs: application of the ESTRO-HERO model in Spain

2. Coverage with evidence development program on stereotactic body radiotherapy in Belgium (2013–2019): a nationwide registry-based prospective studyResearch in context

Catalog

Books, media, physical & digital resources

3. Utilisation of radiotherapy in lung cancer: A scoping narrative literature review with a focus on the introduction of evidence-based therapeutic approaches in Europe

4. Incidence and radiotherapy treatment patterns of complicated bone metastases

5. Correction: Evaluating the health and health economic impact of the COVID-19 pandemic on delayed cancer care in Belgium: A Markov model study protocol.

6. ARCHERY: a prospective observational study of artificial intelligence-based radiotherapy treatment planning for cervical, head and neck and prostate cancer – study protocol

7. Patient-reported outcomes and functional exercise capacity in a real-life setting in non-small cell lung cancer patients undergoing stereotactic body radiotherapy: the Lung PLUS study

8. Dose-volume-based evaluation of convolutional neural network-based auto-segmentation of thoracic organs at risk

9. Hypofractionation Adoption in Prostate Cancer Radiotherapy: Results of an International Survey

10. Cancer treatment data available in European cancer registries: Where are we and where are we going?

11. Evaluating the health and health economic impact of the COVID-19 pandemic on delayed cancer care in Belgium: A Markov model study protocol.

12. Hypofractionation in Breast Cancer Radiotherapy Across World Bank Income Groups: Results of an International Survey

13. Global Radiotherapy: Current Status and Future Directions—White Paper

14. Adopting Health Economic Research in Radiation Oncology: A Perspective From Low- or Middle-Income Countries

15. IASLC Lung Cancer Staging Project: The New Database to Inform Revisions in the Ninth Edition of the TNM Classification of Lung Cancer

16. European Groundshot—addressing Europe's cancer research challenges: a Lancet Oncology Commission

17. Completeness of Reporting Oligometastatic Disease Characteristics in the Literature and Influence on Oligometastatic Disease Classification Using the ESTRO/EORTC Nomenclature

18. The correlation between pre-treatment symptoms, acute and late toxicity and patient-reported health-related quality of life in non-small cell lung cancer patients

19. Radiotherapy prioritization in 143 national cancer control plans: Correlation with radiotherapy machine availability, geography and income level

20. Health service planning to assess the expected impact of centralising specialist cancer services on travel times, equity, and outcomes

22. Treatment of Oligometastatic Non-Small Cell Lung Cancer: An ASTRO/ESTRO Clinical Practice Guideline

23. The International Association for the Study of Lung Cancer Thymic Epithelial Tumor Staging Project: Unresolved Issues to be Addressed for the Next Ninth Edition of the TNM Classification of Malignant Tumors

24. Joint EANM/SNMMI/ESTRO practice recommendations for the use of 2-[F-18]FDG PET/CT external beam radiation treatment planning in lung cancer V1.0

25. Neurocognitive functioning following lung cancer treatment: The PRO-Long Study

26. ProCaLung – Peer review in stage III, mediastinal node-positive, non-small-cell lung cancer: How to benchmark clinical practice of nodal target volume definition and delineation in Belgium☆

28. The International Association for the Study of Lung Cancer Lung Cancer Staging Project : overview of challenges and opportunities in revising the nodal classification of lung cancer

30. The IASLC Lung Cancer Staging Project: Overview of Challenges and Opportunities in Revising the Nodal Classification of Lung Cancer

31. Perspective paper about the joint EANM/SNMMI/ESTRO practice recommendations for the use of 2-[18F]FDG-PET/CT external beam radiation treatment planning in lung cancer

33. Innovation, value and reimbursement in radiation and complex surgical oncology: time to rethink

34. Variable and fixed costs in NHS radiotherapy; consequences for increasing hypo fractionation

36. Is Clinical Research Serving the Needs of the Global Cancer Burden? An Analysis of Contemporary Global Radiation Therapy Randomized Controlled Trials

37. Correction to: Joint EANM/SNMMI/ESTRO practice recommendations for the use of 2-[18F]FDG PET/CT external beam radiation treatment planning in lung cancer V1.0

39. Application of an Ultrasensitive NGS-Based Blood Test for the Diagnosis of Early-Stage Lung Cancer: Sensitivity, a Hurdle Still Difficult to Overcome